Peter Russel was one of the patients in Canada that underwent trial bone regenerative surgery that can entirely change the way reconstructive procedures are being done.
The 60-year-old had lost his lower right jaw to a benign tumor in 2003 and had lost all hope. But, when he heard of the clinical trial, he wanted to give it a try and was happy with the results.
He has also regrown about seven centimeters of bone within two years of the surgery. The surgery that went for four hours did not leave any scar marks, and he was released from the hospital within two days.
The technique used was pioneered by Dr. Cameron Clokie that allowed the reversal of skeletal clock so that the bones can be forced to grow just like in babies.
According to Dr. Cameron Clokie, it is like going back to the embryonic stage of the bone generation, and the results have been excellent with the new bones being as similar to the one that Peter had lost.
The procedure was conducted at Toronto General Hospital and Mount Sinai Hospital and marks for a significant milestone in the tissue generation practices being performed today.
It was Dr. Cameron Clokie who gave a new life to Peter Russel who had lost all hope till he received the phone call about the surgery. Dr. Cameron Clokie is a well-known surgeon who is known for his extensive contribution to the research in regenerative medicine.
While one can find many different types of doctors in the field, he is the one who takes his practice seriously, and it is seen with the number of patients that he sees every year.
Dr. Cameron Clokie has a clinic in Toronto where he sees numerous patients each day, but he also likes to travel to different parts of the world to make people aware of the new technology and procedure in the regenerative bone.
According to Bloomberg, Cameron Clokie is also on the lookout for people who are the best people for such procedure and give them a chance to live a normal life again.
He also runs a successful company with the name of Induce Biologic Inc that conducts research and trials on musculoskeletal reconstruction.